Last reviewed · How we verify
NCT03531580
Comparing Brain Images Before and After MRI-upgrade - TimFit Upgrade Study
NA trial testing Magnetic Resonance Imaging in Neuroimaging in 6 participants. Completed in 30 June 2018.
30 June 2018
Quick facts
| Lead sponsor | University Ghent |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 6 |
| Start date | 29 November 2017 |
| Primary completion | 30 June 2018 |
| Estimated completion | 30 June 2018 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- Magnetic Resonance Imaging
Conditions studied
- Neuroimaging — all drugs for Neuroimaging →
- Quality Control — all drugs for Quality Control →
Sponsor
University Ghent
Who can join
20 and older, any sex, with Neuroimaging or Quality Control. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In the Ghent University, an upgrade of the MRI-scanner used for research from Siemens Trio Tim to Siemens Prisma Fit is planned in the near future. As a change of MRI hard- and software might influence brain images, it is necessary to evaluate the images before and after the upgrade.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03531580
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Magnetic Resonance Imaging
Trials testing the same drug.
- NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
- NCT07229339 — Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer · Phase 2 · not yet recruiting
- NCT07441681 — Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive · Phase 3 · not yet recruiting
- NCT07147231 — Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cem · Phase 1, PHASE2 · recruiting
- NCT06448286 — PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glio · Phase 3 · not yet recruiting
Other recruiting trials for Neuroimaging
Currently open trials in the same condition.
- NCT05698511 — Neural and Physiological Correlates of Psychedelic Sub-states · Phase 1 · active not recruiting
- NCT04810858 — Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury · NA · recruiting
- NCT04951700 — Aging and Disease Course: Contributions to Lifespan Neurobiology of Schizophrenia · active not recruiting
Other University Ghent trials
Trials by the same sponsor.
- NCT07398053 — General Practitioner & Pharmacist Support for Discontinuing Long-term Antidepressants in Clinically Stable Patients · NA · not yet recruiting
- NCT07343258 — Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline · NA · recruiting
- NCT07091071 — Evaluation of the CochSyn Device in Clinical Practice · NA · completed
- NCT07259408 — Co-creation of Tools for People in Detention With Suicidal Thoughts and/or Behavior · recruiting
- NCT07176156 — Evaluation of the Quality of Chat Conversations With the Suicide Helpline Zelfmoordlijn 1813 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03531580 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Ghent
- Last refreshed: 1 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03531580.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing